생쥐 뇌소교세포주에서 웅담추출활성성분(우르소데옥시콜린산)의항산화 및 세포보호효과

초록

The in vitro cytoprotective and anti-oxidative effects of ursodeoxycholic acid, a major active compound from bear’s gall were investigated in mouse brain microglia. In the present study, we wished to scrutinize the potential role of UDCA as an anti-neurodegenerative agent in neurodegenerative disease such as Alzheimer’s disease. This concept was supported by the multiple preliminary studies in which UDCA has an anti-inflammatory effect in microglial cells. In the study, we found that 7.5 µg/mL UDCA was effective in the protection of cells from H2O2 damage, a reactive oxygen, and the result was coincided with the anti-apoptotic effect in DAPI staining. Moreover, the metal-catalyzed oxidation study showed that UDCA has antioxidant effect as much as ascorbic acid at 50~100 µg/mL. In conclusion, these study results suggested that neuro-degenerative diseases such as Alzheimer’s disease probably caused by over-expressed beta amyloid peptide in elderly people can be controled by UDCA through an anti-inflammatory, anti-oxidative and anti-apoptotic effect. The evidences showed in the study may be references for more in-depth in vivo and clinical studies for a candidate of anti-neurodegenerative therapy in the near future.